1.    Wang J, M, Liu, X, Zhang, et al. Physiological and pathophysiological implications of PGE and the PGE synthases in the kidney [J].Prostaglandins & other lipid mediators,2018,134:1-6.

2.    James V Michael, Adelina Gavrila, Ajay P Nayak, et al. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle [J].FASEB J: Official Publication of the Federation of American Societies for Experimental Biology, 2019, 33(4): 4780-4789.

3.    Yukihiko Sugimoto, Shuh Narumiya. Prostaglandin E receptors [J]. J Biol Chem, 2007, 282(16): 11613-11617.

4.    Jean B Regard, Isaac T Sato, Shaun R Coughlin. Anatomical profiling of G protein-coupled receptor expression [J].Cell, 2008, 135(3): 561-71.

5.    Arantzazu Alfranca, Miguel A Iniguez, Manuel Fresno, et al. Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases [J].Cardiovasc Res, 2006, 70(3): 446-56.

6.    Utako Yokoyama, Kousaku Iwatsubo, Masanarl Umemura, et al. The prostanoid EP4 receptor and its signaling pathway [J].Pharmacological Reviews, 2013, 65(3): 1010-52.

7.    Brian K Kobilka. G protein coupled receptor structure and activation [J].Biochim Biophys Acta, 2007, 1768(4): 794-807.

8.    Shinsuke Mizoguchi, Amanda S Wolf-Johnson, Jian-shu Ni, et al. The role of prostaglandin and E series prostaglandin receptor type 4 receptors in the development of bladder overactivity in a rat model of chemically induced prostatic inflammation [J].BJU International, 2019, 124(5): 883-891.

9.    Chandramohan Natarajan, Aaron N Hata, Heldi E Hamm, et al. Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor [J].Molecular Pharmacology, 2013, 83(1): 206-216.

10.  Yosuke Toyoda, Kazushi Morimoto, Ryoji Suno, et al. Ligand binding to human prostaglandin E receptor EP at the lipid-bilayer interface [J].Nature Chemical Biology, 2019, 15(1): 18-26.

11.  Lamine Aoudjit, Anna Potapov, Tomoko Takano. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor [J].Am J Physiol Renal Physiol, 2006, 290(6): F1534-42.

12.  Emi Yamamoto, Takeshi Izawa, Mitsuru Kuwamura, et al. Immunohistochemical expressions of main PGE(2) biosynthesis-related enzymes and PGE(2) receptor in rat nephrogenesis [J].J Toxicologic Pathology, 2011, 24(4): 257-61.

13.  Boye L Jensen, Jane Stubbe, Pernille Hansen, et al. Localization of prostaglandin E(2) EP2 and EP4 receptors in the rat kidney [J].American J Physiology Renal Physiology, 2001, 280(6): F1001-F1009.

14.  Morath R, Thomas Klein, H W Seyberth, et al. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney [J].J the American Society of Nephrology : JASN, 1999, 10(9): 1851-60.

15.  Tessa A Castleberry, Bi-hong Lu, Steven L Smock, et al. Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype [J].Prostaglandins & Other Lipid Mediators, 2001, 65(4): 167-187.

16.  Ren Yi-lin, Martin A D'Ambrosio, Jeffrey L Garvin, et al. Prostaglandin E2 mediates connecting tubule glomerular feedback [J].Hypertension (Dallas, Tex: 1979), 2013, 62(6): 1123-1128.

17.  Nitta M, Ichiro Hirata, K Toshina, et al. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329 [J].Scandinavian J Immunology, 2002, 56(1): 66-75.

18.  Chabha Benyahia, Ingrid Gomez, L Kanyinda, et al. PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy? [J].Pulmonary Pharmacology & Therapeutics, 2012, 25(1): 115-118.

19.  Nabll Foudi, Kotelevets L, Louedec L, et al. Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype [J].Br J Pharmacol, 2008, 154(8): 1631-1639.

20.  Konya V, Üllen A, Kampitsch N, et al. Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking [J]. The J Allergy and Clinical Immunology, 2013, 131(2): 532-40.e1-2.

21.  Petra Luschnig-Schratl, Eva M Sturm, Viktoria Konya, et al. EP4 receptor stimulation down-regulates human eosinophil function [J].Cellular and MolecularLife Sciences : CMLS, 2011, 68(21): 3573-3587.

22.  Sonia Philipose, Viktoria Konya, Ivana Sreckovic, et al. The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation [J].Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, 30(12): 2416-2423.

23.  Vukicevic S, Simic P, Borovecki F, et al. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure [J].Kidney International, 2006, 70(6): 1099-1106.

24.  Liu Yu, Madhumitha Rajagopal, Kim Lee, et al. Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia [J].American J Physiology Renal Physiology, 2012, 303(10): F1425- F1434.

25.  Martin Leduc, Billy Breton, Celine Galés, et al. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands [J].The J Pharmacology and Experimental Therapeutics, 2009, 331(1): 297-307.

26.  Hiromichi Fujino, John W Regan. EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein [J].Molecular Pharmacology, 2006, 69(1): 5.

27.  Madhu B Anand-Srivastava. Modulation of Gi proteins in hypertension: role of angiotensin II and oxidative stress [J].Curr Cardiol Rev, 2010, 6(4): 298-308.

28.  Hiromichi Fujino, Kimberly A West, John W Regan Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 [J].The J Biological Chemistry, 2002, 277(4): 2614-2619.

29.  Fujino Hiromichi, Xu Wei, John W Regan. Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases [J].The J Biological Chemistry, 2003, 278(14): 12151-12156.

30.  Peng Xiao-jie, Li Jian-zhong, Tan si-wei, et al. COX-1/PGE/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis [J].Scientific Reports, 2017, 7(1): 1055.

31.  Jonathan Constance, Alfred Balch, Chris Stockmann, et al. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates [J].Archives of Disease in Childhood. Fetal and Neonatal Edition, 2016, 101(3): F236-43.

32.  Constance J E, D Reith, R M Ward, et al. Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin [J]. J Perinatology : Official J the California Perinatal Association, 2017, 37(10): 1093-1102.

33.  Stefanie Frölich, Anke Olliges, Nikias Kern, et al. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition [J].American J Physiology. Renal Physiology, 2012, 303(2): F209-19.

34.  Lamine Aoudjit, Anna Potapov, Tomoko Takano. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor [J].American J Physiology Renal physiology, 2006, 290(6): F1534- F1542.

35.  Maria Augusta Gaspar. Renovascular hypertension: The current approach [J].Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2019, 38(12): 869-871.

36.  Silva B R, L Pernomian, Tiago Dai-Cin De Paula, et al. Endothelial nitric oxide synthase and cyclooxygenase are activated by hydrogen peroxide in renal hypertensive rat aorta [J].European J Pharmacology, 2017, 814: 87-94.

37.  Carie S Facemire, Robert Griffiths, Laurent P Audoly, et al. The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background [J].Hypertension (Dallas, Tex: 1979), 2010, 55(2): 531-538.

38.  Zhang Dong-juan, Chen Li-hong, Zhang Ya-hua, et al. Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1 [J].Acta Pharmacologica Sinica, 2010, 31(10): 1284-1292.

39.  Chen Li-hong, Miao Yi-fei, Zhang Ya-hua, et al. Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility [J].Arteriosclerosis, Thrombosis, and Vascular Biology, 2012, 32(12): 3024-3032.

40.  Liu Bin, Wu Xiang-zhong, Zeng Ru-hui, et al. Prostaglandin E sequentially activates E-prostanoid receptor-3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature [J].FASEB J : official publication of the Federation of American Societies for Experimental Biology, 2020, 34(2): 2568-2578.

41.  Laurent P Audoly, Stephen L Tilley, Jennifer Goulet, et al. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2 [J].The American J Physiology, 1999, 277(3): H924-30.

42.  Hao C M, Breyer M D. Physiologic and pathophysiologic roles of lipid mediators in the kidney [J].Kidney International, 2007, 71(11): 1105-1115.

43.  Frank Schweda, Jurgen Klar, Shuh Narumiya, et al. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys [J].American J Physiology. Renal Physiology, 2004, 287(3): F427-F433.

44.  Ulla G Friis, Jane Stubbe, Torhen R Uhrenholt, et al. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells [J].Am J Physiol Renal Physiol, 2005, 289(5): F989-97.

45.  Shigeo Negi, Daisuke Koreeda, Sou Kobayashi, et al. Acute kidney injury: Epidemiology, outcomes, complications, and therapeutic strategies [J].Seminars in Dialysis, 2018, 31(5): 519-527.

46.  Stephanie F Smith, Sarah A Hosgood, Michael L Nicholson. Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells [J].Kidney International, 2019, 95(1): 50-56.

47.  Maryam Malek, Mehdi Nematbakhsh. Renal ischemia/reperfusion injury; from pathophysiology to treatment [J].J Renal Injury Prevention, 2015, 4(2): 20-27.

48.  Nur Arfian, Santosa Budiharjo, Dian Prasetyo Wibisono, et al. Vitamin D ameliorates kidney ischemia reperfusion injury via reduction of inflammation and myofibroblast expansion [J].The Kobe J Medical Sciences, 2020, 65(4): E138-E143.

49.  Li Feng, Edward Suarez Moreira Bahnson, Jennifer Wilder, et al. Oral high dose vitamin B12 decreases renal superoxide and post-ischemia/reperfusion injury in mice [J].Redox Biology, 2020, 32: 101504.

50.  Jeremiah Ogbadu, Gaaminepreet Singh, Kirti Gupta, et al. Ageing reduces angiotensin II type 1 receptor antagonism mediated pre-conditioning effects in ischemic kidneys by inducing oxidative and inflammatory stress [J].Experimental Gerontology, 2020, 135(1): 110892.

51.  Rinaldo Bellomo, John A Kellum, Claudio Ronco. Acute kidney injury [J].BMJ Clinical Evidence, 2011, 380(9843): 756-766.

52.  Klaus Höcherl, Christoph Schmidt, Michael Bucher. COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex [J].Kidney international,2009,75(4):373-80.

53.  Ding Chen-guang, Han Feng, Heli Xiang, et al. Role of prostaglandin E2 receptor 4 in the modulation of apoptosis and mitophagy during ischemia/reperfusion injury in the kidney [J].Mol Med Rep, 2019, 20(4): 3337-3346.

54.  Christina Preising, Reinhard Schneider, Michael Bucher, et al. Regulation of expression of renal organic anion transporters OAT1 and OAT3 in a model of ischemia/reperfusion injury [J].Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, 37(1): 1-13.

55.  Deng Cong, Chen Shan-shan, Li Xiong-feng, et al. Role of the PGE2 receptor in ischemia-reperfusion injury of the rat retina [J].Molecular Vision, 2020, 26: 36-47.

56.  Zhu Li-yuan, Xu Chuan-sheng, Huo Xing-yu, et al. The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury [J].Nature Communications, 2019, 10(1): 1888.

57.  Cai Lin-lin, Xu Hai-tao, Wang Qi-long, et al. EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition [J].International J Molecular Medicine, 2020, 45(6):1825-1837.

58.  Christoph Sauvant, R Schneider, Hildegard Holzinger, et al. Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model [J].American J Nephrology, 2010, 32(1): 57-65.

59.  Hong Yu-Ah, Keum-Jin Yang, So-Young Jung, et al. Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E receptor EP4 [J].Kidney Research and Clinical Practice, 2017, 36(2): 145-158.

60.  Yu Ah Hong, Keum-Jin Yang, So Young Jung, et al. Paricalcitol pretreatment attenuates renal ischemia-reperfusion injury via prostaglandin E receptor EP4 pathway [J].Oxidative Medicine and Cellular Longevity, 2017, 2017(3):1-17.

61.  Robert W Schrier, Wang Wei. Acute renal failure and sepsis [J].New England J Medicine, 2004, 351(2): 159-169.

62.  Makita N, Manaka K, Sato J, et al. V2 vasopressin receptor mutations [J]. Vitamins and Hormones, 2020, 113: 79-99.

63.  Daniel G Bichet. Vasopressin receptor mutations in nephrogenic diabetes insipidus [J]. Semin Nephrol, 2008, 28(3): 245-51.

64.  Nielsen S, Tae-Hwan Kwon, Jorgen Frøkiaer, et al. Regulation and dysregulation of aquaporins in water balance disorders [J].J Internal Medicine, 2007, 261(1): 53-64.

65.  Tae-Hwan Kwon, Henrik Hager, Lene Nejsum, et al. Physiology and pathophysiology of renal aquaporins [J].Seminars in Nephrology, 2001, 21(3): 231-238.

66.  Daniel G Bichet. Nephrogenic diabetes insipidus [J].Current Opinion in Pediatrics, 2017, 29(2): 199-205.

67.  Li Jian-hua, Chou Chung-lin, Li Bo, et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus [J].The J Clinical Investigation, 2009, 119(10): 3115-3126.

68.  Jeff M Sands, Harold E Layton. Advances in understanding the urine-concentrating mechanism [J].Annu Rev Physiol, 2014, 76: 387-409.

69.  Tae-Hwan Kwon, Jørgen Frøkiær, Søren Nielsen. Regulation of aquaporin-2 in the kidney: A molecular mechanism of body-water homeostasis [J].Kidney Research and Clinical Practice, 2013, 32(3): 96-102.

70.  Hanne B Moeller, Jeppe Praetorius, Michael R Rützler, et al. Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions [J].Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(1): 424-429.

71.  Emma Tina Bisgaard Olesen, Michael Rutzler, Hanne B Moeller, et al. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus [J].Proc Natl Acad Sci USA, 2011, 108(31): 12949-12954.

72.  Gao Min, Cao Rong, Du Sheng-nan, et al. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts [J].Proceedings of the National Academy of Sciences of the United States of America, 2015, 112(27): 8397-8402.

73.  Karthrin Eller, Tobias Weber, Monika Pruenster, et al. CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells [J].Journal of the American Society of Nephrology : JASN, 2010, 21(1): 42-52.

74.  Dominik Wolf, Kathrin Hochegger, Anna M Wolf, et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice [J].J the American Society of Nephrology : JASN, 2005, 16(5): 1360-1370.

75.  Chadban S J, Atkins R C. Glomerulonephritis [J].Lancet (London, England), 2005, 365(9473): 1797-1806.

76.  Tadashi Nagamatsu, Hirohito Imai, Michiyo Yokoi, et al. Protective effect of prostaglandin EP4-receptor agonist on anti-glomerular basement membrane antibody-associated nephritis [J].J Pharmacological Sciences, 2006, 102(2): 182-188.

77.  Riyaz Mohamed, Calpurnla Jayakumar, Ganesan Ramesh. Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6 [J]. Laboratory Investigation: A J Technical Methods and Pathology, 2013, 93(8): 933-945.

78.  Kazuhiro Furuhashi, Naotake Tsuboi, Asuka Shimizu, et al. Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages [J].J the American Society of Nephrology : JASN, 2013, 24(4): 587-603.

79.  Ida Aringer, Katharina Artinger, Alexander H Kirsch, et al. Blockade of prostaglandin E receptor 4 ameliorates nephrotoxic serum nephritis [J].American J Physiology. Renal Physiology, 2018, 315(6): F1869-F1880.

80.  Lin Yu-sheng, Mingli Hsieh, Yi-Ju Lee, et al. AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells [J]. Nitric Oxide : Biology and Chemistry, 2008, 18(2): 93-104.

81.  Jose M López-Novoa, Carlos Martínez-Salgado, Ana B Rodríguez-Peña, et al. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives [J]. Pharmacology & Therapeutics, 2010, 128(1): 61-81.

82.  Duan Jia-yu, Duan Guang-Cai, Wang Chong-Jian, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey [J].BMC Nephrology, 2020, 21(1): 115.

83.  Hiddo Lambers Heerspink, Dick de Zeeuw. Novel drugs and intervention strategies for the treatment of chronic kidney disease [J]. British J Clinical Pharmacology, 2013, 76(4): 536-550.

84.  Karina Thieme, Syamantak Majumder, Angela S Brijmohan, et al. EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease [J].Scientific Reports, 2017, 7(1): 3442.

85.  Francisco J Lopez-Hernandez, Jose M Lopez-Novoa. Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects [J]. Cell Tissue Res, 2012, 347(1): 141-154.

86.  Yang Guang-Xia, Xu Yu-yin, Fan Ya-Ping, et al. A maladaptive role for EP4 receptors in mouse mesangial cells [J].PLoS One, 2014, 9(8): e104091.

87.  Kazuhiko Mizukami, Hiroyuki Yoshida, Eisuke Nozawa, et al. Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats [J].Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392(4): 451-459.

88.  Hu Chun, Sun Lin, Xiao Ya-chun, et al. Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy [J].Current Medicinal Chemistry, 2015, 22(24): 2858-2870.

89.  Peng Fang-Fang, Xiao Ze-Ling, Chen Hong-Min, et al. Parathyroid hormone inhibits TGF-β/Smad signaling and extracellular matrix proteins upregulation in rat mesangial cells [J].Biochemical and Biophysical Research Communications, 2016, 478(3): 1093-1098.

90.  Convento M S, E Pessoa, M A Dalboni, et al. Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage [J].Urological Research, 2011, 39(1): 21-27.

91.  Tadashi Nagamatsu, Toshiyuki Nagao, Jun-ichi Koseki, et al. Involvement of prostaglandin E2 in clearance of aggregated protein via protein kinase A in glomeruli [J]. Japanese J Pharmacology, 2001, 85(2): 139-145.

92.  Cao Ying-Jie, Pan Tian-Yi, Chen Xiao-xian, et al. EP4 knockdown alleviates glomerulosclerosis through Smad and MAPK pathways in mesangial cells [J].Molecular Medicine Reports, 2018, 18(6): 5141-5150.

93.  Erin M Stitt-Cavanagh, Wissam H Faour, Kaede Takami, et al. A maladaptive role for EP4 receptors in podocytes [J]. J the American Society of Nephrology: JASN, 2010, 21(10): 1678-1690.

94.  Peter Harris, Sandro Rossetti. Molecular diagnostics for autosomal dominant polycystic kidney disease [J].Nature Reviews. Nephrology, 2010, 6(4): 197-206.

95.  Hannah C Chapin, Michael Joseph Caplan. The cell biology of polycystic kidney disease [J].J Cell Biol, 2010, 191(4): 701-710.

96.  Thomas Natoli, Tiffany C Gareski, William R Dackowski, et al. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures [J].Am J Physiol Renal Physiol, 2008, 294(1): F73-83.

97.  Gerard Elberg, Dorit Elberg, Teresa V Lewis, et al. EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells [J].American J Physiology. Renal Physiology, 2007, 293(5): F1622-F1632.

98.  Malcolm R Ogborn, Evan Nitschmann, Nitschmann Bankovic-Calic, et al. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease [J].Kidney International, 2003, 64(4): 1214-1221.

99.  Franck A Belibi, Gail Reif, Darren P Wallace, et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells [J].Kidney International, 2004, 66(3): 964-973.

100. Anll Karihaloo, Christian Nickel, Lloyd G Cantley. Signals which build a tubule [J]. Nephron Experimental Nephrology, 2005, 100(1): e40-e45.